Medical information Clinical review pending

Infection Testing

CMV RNA Detection Qualitative Test

Detects the presence of Cytomegalovirus (CMV) RNA in patients, especially those with weakened immune systems. This test uses Real-Time PCR for accurate detection in serum, plasma, whole blood, or biopsies.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Serum, plasma, whole blood (EDTA tube), or tissue biopsy.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. Confirm with the laboratory before booking.

Test priceKSh 11,560

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CMV RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected CMV infection in immunocompromised patients
✓Monitoring for CMV reactivation in transplant recipients
✓Diagnosis of congenital CMV infection in newborns
✓Evaluation of unexplained fever or illness in immunocompromised individuals
✓Pre-transplant screening in certain cases

In plain language

What this test helps you understand

This test helps identify active CMV infection, guiding treatment decisions, especially in high-risk populations like transplant recipients, immunocompromised individuals, and newborns with suspected congenital CMV.

The CMV RNA Detection Qualitative Test is a vital diagnostic tool used to detect the presence of Cytomegalovirus (CMV) in patients, particularly those who are immunocompromised. CMV is a common virus that can cause severe complications in individuals with weakened immune systems, such as organ transplant recipients, HIV/AIDS patients, and newborns. Early detection is crucial for effective management and treatment.

This test measures the presence of CMV RNA in various sample types, including serum, plasma, whole blood, and biopsies. By utilizing the Real-Time PCR method, the test provides accurate and timely results, allowing healthcare providers to make informed decisions regarding patient care.

Taking the CMV RNA Detection Qualitative Test offers several benefits, including early detection of CMV which can lead to timely intervention and treatment, monitoring viral load in immunocompromised patients, and informing healthcare providers about potential complications related to CMV.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Confirm with the laboratory before booking.

SampleSerum, plasma, whole blood (EDTA tube), or tissue biopsy.

MethodologyReal-Time Polymerase Chain Reaction (PCR).

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This is a qualitative test; it detects the presence of CMV RNA but does not quantify the viral load. False negatives can occur if the viral load is below the test's detection limit or if the sample is collected improperly. False positives are rare but possible due to contamination.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

A positive result indicates that CMV RNA was detected in the sample, suggesting an active CMV infection or reactivation. Your doctor will interpret this result in the context of your clinical situation.

A negative result means that CMV RNA was not detected in the sample. However, it does not completely rule out CMV infection, especially if the viral load is low.

This test is primarily recommended for individuals with weakened immune systems (e.g., organ transplant recipients, HIV/AIDS patients, chemotherapy patients), newborns with symptoms, or those with unexplained symptoms suggestive of CMV.

The sample is typically collected as a blood draw (serum, plasma, or whole blood) or a tissue biopsy, depending on the clinical context. Your doctor will advise on the appropriate sample type.

Generally, no specific preparation is needed. However, please confirm any specific instructions with the laboratory or your doctor.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp